Our Company

Rewriting the biology of aging.

We are advancing a pipeline of novel small molecule therapeutics by unraveling complex biology. Built on pioneering science from our co-founder at MIT, and powered by a world-class team of innovators.

Our discoveries have been featured in Nature, Nature Aging, Nature Protocols, and Cell.

Laboratory research
Leadership

Meet the team.

Felix Wong, PhD

Felix Wong, PhD

Chief Executive Officer & Co-founder

Former NIH-funded fellow at the Broad Institute. Over 30 papers in Nature, Science, and Cell.

Max Wilson, PhD

Max Wilson, PhD

Chief Technology Officer & Co-founder

Associate Professor at UC Santa Barbara. Pioneer in optogenetic systems.

Dan Anderson, PhD

Dan Anderson, PhD

Chief Scientific Officer

20+ years in biotech. Former CSO of Eikon Therapeutics with 130+ scientists.